Viatris Inc. VTRS
17.83
0.41
2.35%
as of 25 Sep
- Market cap
- $20.0B
- P/E
- 0.0×
Follow VTRS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Viatris Inc. (VTRS) Gross margin
Viatris Inc.'s gross margin over the twelve months to 30 June 2026 was 34.8%, down 0.2 percentage points from fiscal 2025 (35.1%). Over the past ten years it has ranged from 31.2% (fiscal 2021) to 44.7% (fiscal 2015); the current reading is higher than 45% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 53.9% and below the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 35.1% | (3.09) |
| FY2024 | 38.2% | (3.59) |
| FY2023 | 41.7% | 1.79 |
| FY2022 | 40.0% | 8.78 |
| FY2021 | 31.2% | (0.61) |
| FY2020 | 31.8% | (2.11) |
| FY2019 | 33.9% | (1.11) |
| FY2018 | 35.0% | (5.17) |
| FY2017 | 40.2% | (2.23) |
| FY2016 | 42.4% | (2.31) |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 38.8% | 5.87 |
| Mar 2026 | 32.9% | 1.91 |
| Dec 2025 | 31.0% | (5.49) |
| Sep 2025 | 36.5% | (0.73) |
| 42 more quarters | Free account |
Against its own ten years
Low 31.2%
High 44.7%
Ten-year median
38.2%
Current reading's percentile
45
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.9% |
| UTHR United Therapeutics Corporation compare | 86.1% |
| ZTS Zoetis Inc. compare | 71.7% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| HLN Haleon PLC Sponsored ADR compare | 62.2% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 52.5% |
| RDY Dr. Reddy's Laboratories Ltd compare | 50.0% |
| VTRS Viatris Inc. | 34.8% |
| Drug Manufacturers Specialty & Generic industry median | 53.9% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on VTRS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement